Where do Royalty Pharma's ratios come from?

Every ratio is computed from Royalty Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Royalty Pharma RPRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	65.1%-18.9pp	65.6%+8.5pp	65.2%-2.9pp	79.8%+36.9pp	83.9%+42.0pp
Net margin	33.9%-14.4pp	32.5%-5.5pp	32.6%-17.9pp	44.3%+14.2pp	48.3%+12.6pp
Returns
Return on equity	8.4%-2.7pp	7.7%-0.7pp	7.7%-3.8pp	10.6%+3.7pp	11.1%+3.0pp
Return on assets	4.4%-2.1pp	4.1%-0.9pp	4.1%-2.7pp	5.7%+1.8pp	6.5%+1.7pp
Return on invested capital	9.2%-2.9pp	8.9%+1.0pp	8.9%-0.9pp	11.3%+5.0pp	12.1%+5.8pp
Efficiency
Asset turnover	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Liquidity
Current ratio	2.7×+1.1×	2.4×+1.0×	3.5×+1.9×	1.3×-8.1×	1.6×-11.0×
Quick ratio	2.7×+1.1×	2.4×+1.0×	3.5×+1.9×	1.3×-8.1×	1.6×-11.0×
Cash ratio	1.1×+0.2×	1×+0.2×	1.8×+1.0×	0.5×-5.9×	0.9×-5.8×
Leverage
Debt-to-equity	0.9×+0.1×	0.9×+0.2×	0.9×+0.2×	0.8×+0.1×	0.8×+0.2×
Debt-to-assets	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.4×0.0×	0.4×+0.1×
Interest coverage	4.7×-3.0×	5.1×-0.7×	5.5×-2.0×	6.9×+1.8×	7.7×+2.6×
Per Share
Book value per share	$17.85+5.5%	$17.21-1.1%	$17.19-0.7%	$16.90+3.4%	$16.91+2.5%
Valuation
Market capitalization	$20.55B+52.4%	$16.51B+45.7%	$15.25B+20.3%	$15.23B+27.7%	$13.49B-0.6%
Enterprise value	$28.94B+44.6%	$24.86B+38.0%	$23.28B+20.4%	$22.62B+27.4%	$20.02B+6.1%
Price / earnings	24.8×+12.5×	21.4×+8.2×	19.9×+8.8×	14.9×-2.8×	12.3×-4.6×
Price / sales	8.4×+2.5×	6.9×+1.9×	6.5×+0.9×	6.6×+1.3×	6×-0.1×
Price / book	2.1×+0.7×	1.7×+0.6×	1.6×+0.3×	1.6×+0.4×	1.4×0.0×
EV / sales	11.9×+3.0×	10.5×+2.5×	9.9×+1.4×	9.8×+1.9×	8.8×+0.4×
Earnings yield	4%-4.1pp	4.7%-2.9pp	5%-4.0pp	6.7%+1.1pp	8.1%+2.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Royalty Pharma.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Royalty Pharma's ratios come from?: Every ratio is computed from Royalty Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.